Palatin Technologies, Inc.
General ticker "PTN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $15.0M (TTM average)
Palatin Technologies, Inc. does not follow the US Stock Market performance with the rate: -27.0%.
Estimated limits based on current volatility of 8.7%: low 6.49$, high 7.74$
Factors to consider:
- Total employees count: 29 (-3.3%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Going concern doubt, Clinical trial failure, Regulatory and compliance, Commercialization challenges, Intellectual property risks
- Current price 19.5% below estimated low
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-06-30 to 2028-06-29
- 2026-06-30 to 2027-06-30 estimated range: [7.48$, 20.67$]
- 2027-06-30 to 2028-06-29 estimated range: [6.54$, 18.32$]
Short-term PTN quotes
Long-term PTN plot with estimates
Financial data
| YTD | 2024-06-30 | 2025-06-30 | 2026-06-30 |
|---|---|---|---|
| Operating Revenue | $4.49MM | $0.00MM | $13.19MM |
| Operating Expenses | $26.99MM | $17.46MM | $21.85MM |
| Operating Income | $-22.50MM | $-17.46MM | $-8.67MM |
| Non-Operating Income | $-7.24MM | $0.15MM | $0.29MM |
| Interest Expense | $0.02MM | $0.02MM | $0.01MM |
| R&D Expense | $22.40MM | $14.90MM | $12.37MM |
| Income(Loss) | $-29.74MM | $-17.31MM | $-8.38MM |
| Net Income(Loss)* | $-29.74MM | $-17.31MM | $-8.38MM |
| Stockholders Equity | $-0.11MM | $-4.78MM | $6.69MM |
| Assets | $10.74MM | $3.27MM | $8.52MM |
| Operating Cash Flow | $-31.46MM | $-21.31MM | $-13.53MM |
| Capital expenditure | $0.04MM | $0.00MM | $0.05MM |
| Investing Cash Flow | $12.45MM | $3.13MM | $-0.05MM |
| Financing Cash Flow | $20.55MM | $11.21MM | $18.51MM |
| Earnings Per Share** | $-2.02 | $-32.15 | $-2.96 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.